510(k) K991459
K991459 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "COPALIS EBV-M ANTIBODY ASSAY". The FDA issued a decision of Substantially Equivalent on May 14, 1999. The device falls under product code LJN (Antibody Igm, If, Epstein-Barr Virus), a Class I device regulated under 21 CFR 866.3235. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 14, 1999
- Date Received
- April 26, 1999
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- Yes
Device Classification
- Device Name
- Antibody Igm, If, Epstein-Barr Virus
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type